# Design Therapeutics, Inc.: Form 8-K, filed Nov 13, 2023

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: 8-K
- Filed: 2023-11-13
- Accepted by EDGAR: Nov 13, 2023, 16:10 ET
- Period: 2023-11-13
- Accession: 0000950170-23-062937
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000095017023062937/dsgn-20231113.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000095017023062937/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000095017023062937/dsgn-20231113.htm

Filed Nov 13, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-062937. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.